XCUR - Exicure, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Exicure, Inc.

2430 North Halsted Street
Chicago, IL 60614
United States
847 673 1700

Full-time employees13

Key executives

NameTitlePayExercisedYear born
Ms. Sarah LongoriaChief HR & Compliance Officer399.75kN/A1982
Mr. Jung-Sang KimCEO, CFO & DirectorN/AN/A1961
Mr. Joshua MillerChief Accounting Officer & ControllerN/AN/A1976
Mr. Bart AndersonSr. Director of R&DN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Corporate governance

Exicure, Inc.’s ISS governance QualityScore as of 1 June 2023 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder rights: 7; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.